Adimab and Mersana Thereapeutics have partnered to offer integrated antibody discovery and antibody-drug conjugate (ADC) technologies. The alliance provides access to Adimab’s antibodies that have been specifically optimized for use in ADCs together with Mersana’s Fleximer polymer and broad array of customizable linkers for attaching diverse, potent payloads.   “We are excited to couple Mersana’s innovative ADC technology with our platform for use by the pharmaceutical in...